| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |